283 related articles for article (PubMed ID: 18835652)
1. Functional inactivation of NF2/merlin in human mesothelioma.
Thurneysen C; Opitz I; Kurtz S; Weder W; Stahel RA; Felley-Bosco E
Lung Cancer; 2009 May; 64(2):140-7. PubMed ID: 18835652
[TBL] [Abstract][Full Text] [Related]
2. Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
Utermark T; Alekov A; Lerche H; Abramowski V; Giovannini M; Hanemann CO
Cancer; 2003 Apr; 97(8):1955-62. PubMed ID: 12673723
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma.
Kleymenova EV; Bianchi AA; Kley N; Pylev LN; Walker CL
Mol Carcinog; 1997 Jan; 18(1):54-60. PubMed ID: 9022813
[TBL] [Abstract][Full Text] [Related]
5. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
[TBL] [Abstract][Full Text] [Related]
6. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.
Cheng JQ; Lee WC; Klein MA; Cheng GZ; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 1999 Mar; 24(3):238-42. PubMed ID: 10451704
[TBL] [Abstract][Full Text] [Related]
7. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
Horiguchi A; Zheng R; Shen R; Nanus DM
Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
10. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
Stemmer-Rachamimov AO; Gonzalez-Agosti C; Xu L; Burwick JA; Beauchamp R; Pinney D; Louis DN; Ramesh V
J Neuropathol Exp Neurol; 1997 Jun; 56(6):735-42. PubMed ID: 9184664
[TBL] [Abstract][Full Text] [Related]
11. Frequency and distribution of NF2 mutations in schwannomas.
Jacoby LB; MacCollin M; Barone R; Ramesh V; Gusella JF
Genes Chromosomes Cancer; 1996 Sep; 17(1):45-55. PubMed ID: 8889506
[TBL] [Abstract][Full Text] [Related]
12. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
13. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
14. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
[TBL] [Abstract][Full Text] [Related]
15. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
Sato T; Sekido Y
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
Schmucker B; Ballhausen WG; Kressel M
Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
[TBL] [Abstract][Full Text] [Related]
18. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
19. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours.
Fleury-Feith J; Lecomte C; Renier A; Matrat M; Kheuang L; Abramowski V; Levy F; Janin A; Giovannini M; Jaurand MC
Oncogene; 2003 Jun; 22(24):3799-805. PubMed ID: 12802287
[TBL] [Abstract][Full Text] [Related]
20. CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas.
Xu J; Zhang Y; Shi Y; Yin D; Dai P; Zhao W; Zhang T
Otol Neurotol; 2020 Jan; 41(1):e94-e102. PubMed ID: 31789805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]